Accès libre

Parathyroidectomy in a patient treated with emicizumab

Helen Hupston

Helen Hupston

University Hospital, Queen Elizabeth Hospital BirminghamBirmingham, UK
Profil Orcid
Recherchez cet auteur sur
Sciendo|Google Scholar
Hupston, Helen
  
23 déc. 2019
Parathyroidectomy in a patient treated with emicizumab's Cover Image
À propos de cet article
Article précédent
Article suivant
Citez
Télécharger la couverture
Publié en ligne: 23 déc. 2019
Pages: 51 - 53
DOI: https://doi.org/10.17225/jhp00149
Mots clés
© 2019 Helen Hupston, published by Sciendo
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
A patient with haemophilia A and inhibitors undergoing parathyroidectomy continued a standard maintenance dose of emicizumab, with bleed risk managed intra- and postoperatively with recombinant Factor VIIa (rFVIIa) and tranexamic acid. Despite the risk of hypercoagulability with the combination of emicizumab and rFVIIa, no postoperative complications were reported.© Shutterstock
A patient with haemophilia A and inhibitors undergoing parathyroidectomy continued a standard maintenance dose of emicizumab, with bleed risk managed intra- and postoperatively with recombinant Factor VIIa (rFVIIa) and tranexamic acid. Despite the risk of hypercoagulability with the combination of emicizumab and rFVIIa, no postoperative complications were reported.© Shutterstock
Langue:
Anglais
Périodicité:
1 fois par an
Sujets de la revue:
Médecine, Sciences médicales de base, Sciences médicales de base, autres, Médecine clinique, Médecine clinique, autres, Pharmacie, Pharmacologie
RSS Feed de la revue